Warsaw - Delayed Quote PLN
Voxel S.A. (VOX.WA)
146.80
-0.80
(-0.54%)
At close: May 5 at 5:00:00 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
492,414.20
424,182.40
360,635.60
442,660.50
327,640.80
Cost of Revenue
339,444.70
283,834.60
253,285
314,999.20
260,040.40
Gross Profit
152,969.50
140,347.80
107,350.60
127,661.30
67,600.40
Operating Expense
25,033.70
22,839.80
20,759.70
22,486.10
25,491.10
Operating Income
127,935.80
117,508
86,590.90
105,175.20
42,109.30
Net Non Operating Interest Income Expense
-8,584
-10,094.30
-10,245.60
-8,522
-5,697.60
Pretax Income
112,495.20
102,234.30
69,174.40
89,507.40
44,653.30
Tax Provision
22,479.70
20,022.40
13,657.20
17,795.20
10,552.90
Net Income Common Stockholders
89,591.30
74,204.20
44,427.60
70,548.90
33,960.70
Diluted NI Available to Com Stockholders
89,591.30
74,204.20
44,427.60
70,548.90
33,960.70
Basic EPS
9.17
7.70
5.17
6.72
3.23
Diluted EPS
9.17
7.70
5.17
6.72
3.23
Basic Average Shares
10,495.84
10,502.60
10,502.60
10,502.60
10,502.60
Diluted Average Shares
10,495.84
10,502.60
10,502.60
10,502.60
10,502.60
Total Operating Income as Reported
121,725.60
112,718.30
80,289.20
98,341.60
50,440.50
Total Expenses
364,478.40
306,674.40
274,044.70
337,485.30
285,531.50
Net Income from Continuing & Discontinued Operation
89,591.30
74,204.20
44,427.60
70,548.90
33,960.70
Normalized Income
93,990.83
84,580.97
59,363.26
80,376.68
27,628.99
Interest Income
1,639.90
1,310.70
349.90
310.30
300.20
Interest Expense
9,625.70
10,541.20
10,444
5,710
5,535.80
Net Interest Income
-8,584
-10,094.30
-10,245.60
-8,522
-5,697.60
EBIT
122,120.90
112,775.50
79,618.40
95,217.40
50,189.10
EBITDA
166,830.70
151,491.80
117,697.30
131,281.90
84,235.50
Reconciled Cost of Revenue
339,444.70
283,834.60
253,285
314,999.20
260,040.40
Reconciled Depreciation
44,709.80
38,716.30
38,078.90
36,064.50
34,046.40
Net Income from Continuing Operation Net Minority Interest
89,021.60
80,892.90
54,321.90
70,548.90
33,960.70
Total Unusual Items Excluding Goodwill
-6,210.20
-4,789.70
-6,301.70
-6,833.60
8,331.20
Total Unusual Items
-6,210.20
-4,789.70
-6,301.70
-2,472.70
8,331.20
Normalized EBITDA
173,040.90
156,281.50
123,999
133,754.60
75,904.30
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,240.97
-1,101.63
-1,260.34
-1,366.72
1,999.49
12/31/2020 - 10/11/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABDXF Abingdon Health Plc
0.0700
0.00%
LO3A.BE Lonza Group Ltd
64.00
-0.78%
TMOF.VI Thermo Fisher Scientific Inc.
372.75
-0.25%
ESF0.MU Eurofins Scientific SE
56.22
+1.08%
BIOPOR.CO BioPorto A/S
1.5900
+0.63%
SHL.AX Sonic Healthcare Limited
26.21
+0.67%
NOTV Inotiv, Inc.
2.0400
+0.49%
ERF.PA Eurofins Scientific SE
57.70
+1.98%
LONN.SW Lonza Group AG
598.00
-0.30%
ACRS Aclaris Therapeutics, Inc.
1.2800
-11.11%